Autism spectrum disorder (ASD) is a range of neurodevelopmental disorders characterized by movement and social deficits with rapidly increasing incidence worldwide. Propionic acid (PPA) is a histone deacetylase inhibitor that regulates neuronal plasticity in the brain. Evaluation of the behavioral and cellular consequences of PPA exposure during a critical neurodevelopmental window is required. Therefore, in the present study we aimed to evaluate the effects of prenatal PPA exposure on locomotor behavior and astrocyte number, as well as on levels of nitric oxide (NO), synaptophysin (SYP; a marker of synaptic plasticity), and metallothionein 3 (MT-III; a marker of reactive oxygen species and zinc metabolism), in the prefrontal cortex (PFC) of male rats. All parameters were evaluated at three critical ages of development: postnatal days (PD) 21 (weaning age), PD35 (pre-pubertal age) and PD70 (post-pubertal age). Prenatal PPA exposure induced hypolocomotion and decreased rearing events at weaning age. Moreover, astrogliosis in the PFC was observed in PPA-treated rats at pre- and post-pubertal age. SYP levels were dramatically decreased in PPA-treated rats with simultaneous astrogliosis, suggesting reduced synaptic plasticity. MT-III expression was deregulated in PPA-treated rats. Finally, the expression of NO in the PFC remained unaltered in PPA-treated rats. These results mimic behavioral, neuronal and astrocytic characteristics observed in ASD patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jchemneu.2021.102011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Therapeutic effects of pentoxifylline in propionic acid-induced autism symptoms in rat models: A behavioral, biochemical, and histopathological study.
Int J Dev Neurosci
December 2024
Department of Physiology, Demiroğlu Bilim University, Istanbul, Türkiye.
Article Synopsis
- The study investigates the effects of pentoxifylline on autism-like behaviors in rat models induced by propionic acid (PPA), focusing on how it influences brain proteins and inflammatory responses.
- Thirty male Wistar albino rats were divided into three groups: a control group, a PPA group, and a PPA plus pentoxifylline group, with various treatment regimens followed by analysis of brain and blood samples.
- Results showed that pentoxifylline significantly reduced autism-like behaviors, lowered levels of the pro-inflammatory cytokine TNF-α, increased beneficial brain factors like ATP and nerve growth factor, and improved neuronal health, suggesting its potential as a neurotherapeutic agent for autism.
In a rodent model of autism, probiotics decrease gut leakiness in relation to gene expression of GABA receptors: Emphasize how crucial the gut-brain axis.
Transl Neurosci
January 2024
Autism Center, Lotus Holistic Medical Center, Abu Dhabi, 110281, United Arab Emirates.
Article Synopsis
- - This study investigates the link between autism spectrum disorder and gastrointestinal issues using rodent models, focusing on how increased gut permeability might relate to neurotoxic effects from propionic acid (PPA).
- - Forty young male western Albino rats were divided into six groups to test the effects of PPA and different probiotic treatments, measuring factors like intestinal permeability markers (zonulin and occludin) and oxidative stress indicators.
- - Results indicated that probiotics could improve gut barrier function, lower markers of intestinal permeability, enhance GABA receptor expression, and reduce oxidative stress associated with PPA, suggesting potential therapeutic benefits for addressing gut-related issues in autistic individuals.
The enteric metabolite, propionic acid, impairs social behavior and increases anxiety in a rodent ASD model: Examining sex differences and the influence of the estrous cycle.
Pharmacol Biochem Behav
October 2023
Graduate Program in Neuroscience, University of Western Ontario, London, Ontario, Canada; Department of Psychology, University of Western Ontario, London, Ontario, Canada. Electronic address:
Research suggests that certain gut and dietary factors may worsen behavioral features of autism spectrum disorder (ASD). Treatment with propionic acid (PPA) has been found to create both brain and behavioral responses in rats that are characteristic of ASD in humans. A consistent male bias in human ASD prevalence has been observed, and several sex-differential genetic and hormonal factors have been suggested to contribute to this bias.
View Article and Find Full Text PDFBee Pollen and Probiotics' Potential to Protect and Treat Intestinal Permeability in Propionic Acid-Induced Rodent Model of Autism.
Metabolites
April 2023
Central Laboratory, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia.
Rodent models may help investigations on the possible link between autism spectrum disorder (ASD) and gut microbiota since autistic patients frequently manifested gastrointestinal troubles as co-morbidities. Thirty young male rats were divided into five groups: Group 1 serves as control; Group 2, bee pollen and probiotic-treated; and Group 3, propionic acid (PPA)-induced rodent model of autism; Group 4 and Group 5, the protective and therapeutic groups were given bee pollen and probiotic combination treatment either before or after the neurotoxic dose of PPA, respectively. Serum occludin, zonulin, lipid peroxides (MDA), glutathione (GSH), glutathione-S-transferase (GST), glutathione peroxidase (GPX), catalase, and gut microbial composition were assessed in all investigated groups.
View Article and Find Full Text PDFModafinil Improves Autism-like Behavior in Rats by Reducing Neuroinflammation.
J Neuroimmune Pharmacol
June 2023
Department of Biochemistry, Demiroğlu Bilim University, Istanbul, Turkey.
To evaluate the ameliorating effect of Modafinil on neuroinflammation, behavioral, and histopathological alterations in rats induced by propionic acid (PPA). Thirty male Wistar rats were used in the study, divided into 3 groups of ten subjects. One group served as a control, the subjects in the other two were given 250 mg/kg/day of PPA by intraperitoneal injection over the course of 5 days to induce autism.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!